273 related articles for article (PubMed ID: 19828904)
1. Activation of PPAR gamma and alpha by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation.
Hontecillas R; O'Shea M; Einerhand A; Diguardo M; Bassaganya-Riera J
J Am Coll Nutr; 2009 Apr; 28(2):184-95. PubMed ID: 19828904
[TBL] [Abstract][Full Text] [Related]
2. Effects of pomegranate seed oil on glucose and lipid metabolism-related organs in rats fed an obesogenic diet.
Miranda J; Aguirre L; Fernández-Quintela A; Macarulla MT; Martínez-Castaño MG; Ayo J; Bilbao E; Portillo MP
J Agric Food Chem; 2013 May; 61(21):5089-96. PubMed ID: 23682933
[TBL] [Abstract][Full Text] [Related]
3. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
4. Catalpic acid decreases abdominal fat deposition, improves glucose homeostasis and upregulates PPAR alpha expression in adipose tissue.
Hontecillas R; Diguardo M; Duran E; Orpi M; Bassaganya-Riera J
Clin Nutr; 2008 Oct; 27(5):764-72. PubMed ID: 18778878
[TBL] [Abstract][Full Text] [Related]
5. Dietary abscisic acid ameliorates glucose tolerance and obesity-related inflammation in db/db mice fed high-fat diets.
Guri AJ; Hontecillas R; Si H; Liu D; Bassaganya-Riera J
Clin Nutr; 2007 Feb; 26(1):107-16. PubMed ID: 17000034
[TBL] [Abstract][Full Text] [Related]
6. Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism.
Dallaire P; Bellmann K; Laplante M; Gélinas S; Centeno-Baez C; Penfornis P; Peyot ML; Latour MG; Lamontagne J; Trujillo ME; Scherer PE; Prentki M; Deshaies Y; Marette A
Diabetes; 2008 Aug; 57(8):1999-2011. PubMed ID: 18458147
[TBL] [Abstract][Full Text] [Related]
7. Activation of PPARγ and δ by dietary punicic acid ameliorates intestinal inflammation in mice.
Bassaganya-Riera J; DiGuardo M; Climent M; Vives C; Carbo A; Jouni ZE; Einerhand AW; O'Shea M; Hontecillas R
Br J Nutr; 2011 Sep; 106(6):878-86. PubMed ID: 21736821
[TBL] [Abstract][Full Text] [Related]
8. Abscisic acid synergizes with rosiglitazone to improve glucose tolerance and down-modulate macrophage accumulation in adipose tissue: possible action of the cAMP/PKA/PPAR γ axis.
Guri AJ; Hontecillas R; Bassaganya-Riera J
Clin Nutr; 2010 Oct; 29(5):646-53. PubMed ID: 20207056
[TBL] [Abstract][Full Text] [Related]
9. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
[TBL] [Abstract][Full Text] [Related]
10. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue.
Toyoda T; Kamei Y; Kato H; Sugita S; Takeya M; Suganami T; Ogawa Y
Obesity (Silver Spring); 2008 Jun; 16(6):1199-207. PubMed ID: 18356826
[TBL] [Abstract][Full Text] [Related]
11. P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.
Chen W; Zhou XB; Liu HY; Xu C; Wang LL; Li S
Br J Pharmacol; 2009 Jul; 157(5):724-35. PubMed ID: 19422369
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes.
Massaro M; Scoditti E; Pellegrino M; Carluccio MA; Calabriso N; Wabitsch M; Storelli C; Wright M; De Caterina R
Pharmacol Res; 2016 May; 107():125-136. PubMed ID: 26976796
[TBL] [Abstract][Full Text] [Related]
13. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches.
Hidalgo-Figueroa S; Ramírez-Espinosa JJ; Estrada-Soto S; Almanza-Pérez JC; Román-Ramos R; Alarcón-Aguilar FJ; Hernández-Rosado JV; Moreno-Díaz H; Díaz-Coutiño D; Navarrete-Vázquez G
Chem Biol Drug Des; 2013 Apr; 81(4):474-83. PubMed ID: 23289972
[TBL] [Abstract][Full Text] [Related]
14. Licochalcone F alleviates glucose tolerance and chronic inflammation in diet-induced obese mice through Akt and p38 MAPK.
Bak EJ; Choi KC; Jang S; Woo GH; Yoon HG; Na Y; Yoo YJ; Lee Y; Jeong Y; Cha JH
Clin Nutr; 2016 Apr; 35(2):414-421. PubMed ID: 25823386
[TBL] [Abstract][Full Text] [Related]
15. Bavachinin, as a novel natural pan-PPAR agonist, exhibits unique synergistic effects with synthetic PPAR-γ and PPAR-α agonists on carbohydrate and lipid metabolism in db/db and diet-induced obese mice.
Feng L; Luo H; Xu Z; Yang Z; Du G; Zhang Y; Yu L; Hu K; Zhu W; Tong Q; Chen K; Guo F; Huang C; Li Y
Diabetologia; 2016 Jun; 59(6):1276-86. PubMed ID: 26983922
[TBL] [Abstract][Full Text] [Related]
16. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
Abd El-Haleim EA; Bahgat AK; Saleh S
Eur J Pharmacol; 2016 Feb; 773():59-70. PubMed ID: 26825546
[TBL] [Abstract][Full Text] [Related]
17. Regular tart cherry intake alters abdominal adiposity, adipose gene transcription, and inflammation in obesity-prone rats fed a high fat diet.
Seymour EM; Lewis SK; Urcuyo-Llanes DE; Tanone II; Kirakosyan A; Kaufman PB; Bolling SF
J Med Food; 2009 Oct; 12(5):935-42. PubMed ID: 19857054
[TBL] [Abstract][Full Text] [Related]
18. Sparstolonin B inhibits lipopolysaccharide-induced inflammation in 3T3-L1 adipocytes.
Wang M; Xiu L; Diao J; Wei L; Sun J
Eur J Pharmacol; 2015 Dec; 769():79-85. PubMed ID: 26522926
[TBL] [Abstract][Full Text] [Related]
19. Effects of DSP-8658, a novel selective peroxisome proliferator-activated receptors a/γ modulator, on adipogenesis and glucose metabolism in diabetic obese mice.
Goto T; Nakayama R; Yamanaka M; Takata M; Takazawa T; Watanabe K; Maruta K; Nagata R; Nagamine J; Tsuchida A; Kato H
Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):492-9. PubMed ID: 26011171
[TBL] [Abstract][Full Text] [Related]
20. Anti-Inflammatory Effects of Rosiglitazone in Obesity-Impaired Wound Healing Depend on Adipocyte Differentiation.
Siebert A; Goren I; Pfeilschifter J; Frank S
PLoS One; 2016; 11(12):e0168562. PubMed ID: 27992530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
